gatortriada.blogg.se - Vacina hepatite b doses intervalo

241000700721 Hepatitis B virus Species 0.000 claims abstract description 125.208000002672 Hepatitis B Diseases 0.000 claims abstract description 144.239000000427 antigen Substances 0.000 claims abstract description 283.

108091007172 antigens Proteins 0.000 claims abstract description 303.

102000038129 antigens Human genes 0.000 claims abstract description 303.

231100000283 hepatitis Toxicity 0.000 title claims description 10.

208000006454 Hepatitis Diseases 0.000 title claims description 13.

238000002649 immunization Methods 0.000 title claims description 52.

230000003053 immunization Effects 0.000 title claims description 61.

239000000203 mixture Substances 0.000 title claims abstract description 383.

filed Critical Glaxosmithkline Biologicals S.A. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to GBGB1721068.3A priority Critical patent/GB201721068D0/en Priority to GB1721068.3 priority Application filed by Glaxosmithkline Biologicals S.A. Priority date (The priority date is an assumption and is not a legal conclusion. Inventor Virginia Ammendola Babak Bayat Clarisse Lorin Ventzislav Bojidarov Vassilev Alessandra Vitelli Original Assignee Glaxosmithkline Biologicals S.A.